# Vertex to Acquire Crinetics Pharmaceuticals in $10B Endocrine Disease Deal

> ma · REPORTED · 2026-07-01

Vertex announced a definitive agreement to acquire Crinetics Pharmaceuticals, marking a major foray into endocrine disease drugs and significantly expanding Vertex's pipeline beyond its cystic fibrosis franchise. The deal is one of the largest biopharma acquisitions reported in mid-2026.

About Vertex Pharmaceuticals: Crinetics Pharmaceuticals is a clinical-stage company developing novel therapeutics for rare endocrine diseases and endocrine-related tumors, with a pipeline of nonpeptide small molecule drug candidates.

- Company: Vertex Pharmaceuticals
- Sector: therapeutics
- Primary source: https://www.biopharmadive.com/news/biotech-pharma-deals-merger-acquisitions-tracker/604262/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.